Skip to content
Recall Observatory FDA recall evidence

Drug product

Ondansetron Injection USP 40 mg/20 mL (2 mg/mL), Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454 NDC # 0703-7226-01 (20 mL- Multi-dose Vial), NDC # 0703-72263-03 (10 Multi-dose Vials per carton)

D-1497-2016

June 17, 2016

Class II

Product summary

Firm
Teva North America
Event
Event 74497
Status
Terminated
Classification
Class II
Quantity
13,223 vials
Official record key
drug-enforcement:D-1497-2016

Official wording

Reason: CGMP Deviations

Code information: All Lots Within Expiry Lot # 2930614, 2940614, 2950614

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations